Wednesday’s Midday Movers: Rosetta Genomics Ltd (ROSG), ImmunoCellular Therapeutics (IMUC), Curis Inc (CRIS), Keryx Biopharma (KERX), CDTi Advanced Materials Inc (CDTI)

By Carrie Williams

So far Wednesday, December 12, NASDAQ is up 2.2% and the S&P is up 0.74%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Rosetta Genomics Ltd (ROSGResearch Report), ImmunoCellular Therapeutics (IMUCResearch Report), Curis Inc (CRISResearch Report), Keryx Biopharma (KERXResearch Report) and CDTi Advanced Materials Inc (CDTIResearch Report).

Rosetta Genomics Ltd is down -76.06% in midday trading to $0.00. Shares opened today at $0.01. The company has a 52-week low of $0.00 and a 52-week high of $0.00.

ImmunoCellular Therapeutics is up 25% in midday trading to $0.03. Shares opened today at $0.02. The company has a 52-week low of $0.02 and a 52-week high of $0.00.

Curis Inc is up 15.32% in midday trading to $0.72. Shares opened today at $0.62. The company has a 52-week low of $0.60 and a 52-week high of $0.00. On the Street’s front, the average 12-month analyst price target for the stock is $3.00, marking a 383.87% potential upside from current levels. In a report issued on November 1, Robert W. Baird analyst Brian Skorney maintained a Buy rating on CRIS, with a price target of $3, which represents a potential upside of 384% from where the stock is currently trading.

See today’s analyst top recommended stocks >>

Keryx Biopharma is down -13.66% in midday trading to $2.97. Shares opened today at $3.44. The company has a 52-week low of $2.47 and a 52-week high of $0.00. On the Street’s front, the average 12-month analyst price target for the stock is $9.00, marking a 161.63% potential upside from current levels. In a report issued on November 12, Raymond James analyst Reni Benjamin downgraded KERX to Hold. Separately, on November 9, H.C. Wainwright’s Jason Kolbert maintained a Buy rating on the stock and has a price target of $9. In the last 30 days, insiders have sold $6,401 worth of KERX shares. Over the last 3 months, the insider sentiment on Keryx Biopharma has been negative based on 46 corporate insider transactions. This sentiment is lower than the average sector sentiment of insiders.

See today’s analyst top recommended stocks >>

CDTi Advanced Materials Inc is down -13.22% in midday trading to $0.43. Shares opened today at $0.49. The company has a 52-week low of $0.35 and a 52-week high of $0.00.

Trending Stocks Based on Insider Activity >>